UZE:NYE-United States Cellular Preferred 5.500% due 2070 (USD)

COMMON STOCK | |

Last Closing

USD 22.97

Change

-0.06 (-0.26)%

Market Cap

USD 2.74B

Volume

0.09M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-13 )

Largest Industry Peers for

Symbol Name Price(Change) Market Cap
TBB AT&T Inc

-0.12 (-0.50%)

USD 146.86B
PRS Prudential Financial Inc

-0.04 (-0.16%)

USD 44.13B
ALL-PB The Allstate Corporation

+0.03 (+0.11%)

USD 33.68B
SOJC Southern Co

-0.12 (-0.49%)

USD 23.86B
AIZN Assurant Inc

-0.05 (-0.22%)

USD 9.38B
RZB Reinsurance Group of America I..

+0.03 (+0.12%)

USD 8.80B
PCG-PA Pacific Gas and Electric Compa..

-0.03 (-0.12%)

USD 6.63B
PCG-PB Pacific Gas and Electric Compa..

+0.21 (+0.95%)

USD 5.89B
UNMA Unum Group

+0.03 (+0.12%)

USD 5.72B
PCG-PD Pacific Gas and Electric Compa..

N/A

USD 5.31B

ETFs Containing UZE

FPE First Trust Preferred Sec.. 0.49 % 0.85 %

+0.01 (+0.09%)

USD 5.78B
PFFA Virtus InfraCap U.S. Pref.. 0.00 % 2.13 %

+0.02 (+0.09%)

USD 1.40B

Market Performance

  Market Performance vs. Industry/Classification () Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 28.68% N/A N/A 84% B
Dividend Return 5.78% N/A N/A 79% B-
Total Return 34.46% N/A N/A 87% B+
Trailing 12 Months  
Capital Gain 36.48% N/A N/A 82% B
Dividend Return 8.18% N/A N/A 84% B
Total Return 44.66% N/A N/A 85% B
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -4.32% N/A N/A 15% F
Dividend Return -0.45% N/A N/A 20% F
Total Return 3.87% N/A N/A 74% C
Risk Return Profile  
Volatility (Standard Deviation) 24.26% N/A N/A 45% F
Risk Adjusted Return -1.84% N/A N/A 21% F
Market Capitalization 2.74B N/A N/A 70% C-

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Positive cash flow

The company had positive total cash flow in the most recent four quarters.

What to not like:

There is nothing we particularly dislike